Correction: A Jan. 25 story on Recovery Audit Contractor (RAC) targets should have stated Connolly Healthcare is only approved to review outpatient hospital claims billing J0152 (Adenosine injection, $80.92). The original story had mentioned J0150 (injection adenosine, 6 mg, $10.20), but CMS has since clarified the RAC will only target J0152.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.